Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Total Jushi Shareholders' Equity (Deficit)
Common Stock
Subordinate Voting Shares
Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2022     196,686,372      
Balance at beginning of period at Dec. 31, 2022 $ 45,891 $ 47,278   $ 492,020 $ (444,742) $ (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares canceled upon forfeiture of restricted stock, net of restricted stock grants (in shares)     (53,001)      
Share-based compensation (including related parties) 2,311 2,311   2,311    
Net loss (12,440) (12,440)     (12,440)  
Balance at end of period (in shares) at Mar. 31, 2023     196,633,371      
Balance at end of period at Mar. 31, 2023 35,762 37,149   494,331 (457,182) (1,387)
Balance at beginning of period (in shares) at Dec. 31, 2022     196,686,372      
Balance at beginning of period at Dec. 31, 2022 45,891 47,278   492,020 (444,742) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (47,098)          
Balance at end of period (in shares) at Sep. 30, 2023     196,631,598      
Balance at end of period at Sep. 30, 2023 7,832 9,219   501,059 (491,840) (1,387)
Balance at beginning of period (in shares) at Mar. 31, 2023     196,633,371      
Balance at beginning of period at Mar. 31, 2023 35,762 37,149   494,331 (457,182) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Modification and reclassification of warrants 3,391 3,391   3,391    
Share-based compensation (including related parties) 2,363 2,363   2,363    
Net loss (14,036) (14,036)     (14,036)  
Balance at end of period (in shares) at Jun. 30, 2023     196,633,371      
Balance at end of period at Jun. 30, 2023 27,480 28,867   500,085 (471,218) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares canceled upon forfeiture of restricted stock, net of restricted stock grants (in shares)     (1,773)      
Share-based compensation (including related parties) 1,056 1,056   1,056    
Cashless exercise of options (282) (282)   (282)    
Issuance of warrants 200 200   200    
Net loss (20,622) (20,622)     (20,622)  
Balance at end of period (in shares) at Sep. 30, 2023     196,631,598      
Balance at end of period at Sep. 30, 2023 7,832 9,219   501,059 (491,840) (1,387)
Balance at beginning of period (in shares) at Dec. 31, 2023     196,631,598      
Balance at beginning of period at Dec. 31, 2023 (7,619) (6,232)   503,612 (509,844) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued upon exercise of stock options (in shares)     3,333      
Shares issued upon exercise of stock options 2 2   2    
Share-based compensation (including related parties) 1,524 1,524   1,524    
Issuance of warrants 863 863   863    
Net loss (18,355) (18,355)     (18,355)  
Balance at end of period (in shares) at Mar. 31, 2024     196,634,931      
Balance at end of period at Mar. 31, 2024 (23,585) (22,198)   506,001 (528,199) (1,387)
Balance at beginning of period (in shares) at Dec. 31, 2023     196,631,598      
Balance at beginning of period at Dec. 31, 2023 $ (7,619) (6,232)   503,612 (509,844) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued upon exercise of stock options (in shares) 64,999          
Net loss $ (36,309)          
Balance at end of period (in shares) at Sep. 30, 2024     196,696,597      
Balance at end of period at Sep. 30, 2024 (38,686) (38,686)   507,467 (546,153) 0
Balance at beginning of period (in shares) at Mar. 31, 2024     196,634,931      
Balance at beginning of period at Mar. 31, 2024 (23,585) (22,198)   506,001 (528,199) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued upon exercise of stock options (in shares)     8,333      
Shares issued upon exercise of stock options 5 5   5    
Share-based compensation (including related parties) 347 347   347    
Deconsolidation of Jushi Europe 1,387         1,387
Net loss (1,938) (1,938)     (1,938)  
Balance at end of period (in shares) at Jun. 30, 2024     196,643,264      
Balance at end of period at Jun. 30, 2024 (23,784) (23,784)   506,353 (530,137) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued upon exercise of stock options (in shares)     53,333      
Shares issued upon exercise of stock options 32 32   32    
Share-based compensation (including related parties) 1,082 1,082   1,082    
Net loss (16,016) (16,016)     (16,016)  
Balance at end of period (in shares) at Sep. 30, 2024     196,696,597      
Balance at end of period at Sep. 30, 2024 $ (38,686) $ (38,686)   $ 507,467 $ (546,153) $ 0